Mrs Jeanette Frances Kamciyan, RN, MSN, FNP-C | |
21045 Black Maple Ln, Boca Raton, FL 33428-1708 | |
(561) 702-4418 | |
(561) 734-2545 |
Full Name | Mrs Jeanette Frances Kamciyan |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Family |
Location | 21045 Black Maple Ln, Boca Raton, Florida |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053627547 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | RN1207652 (Florida) | Secondary |
363LF0000X | Nurse Practitioner - Family | ARNP1207652 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Jeanette Frances Kamciyan, RN, MSN, FNP-C 21045 Black Maple Ln, Boca Raton, FL 33428-1708 Ph: (561) 702-4418 | Mrs Jeanette Frances Kamciyan, RN, MSN, FNP-C 21045 Black Maple Ln, Boca Raton, FL 33428-1708 Ph: (561) 702-4418 |
News Archive
The North Carolina GlaxoSmithKline Foundation announced that it has awarded $25,000 grants to nine nonprofits this year, around the state to support activities that establish or expand programs that further science, education and health in local communities.
Acorda Therapeutics, Inc. today announced that AMPYRA™ (dalfampridine) Extended Release Tablets, 10 mg is now available by prescription in the United States and Puerto Rico. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is indicated for use in all types of MS, and can be used either alone or with existing therapies, including disease-modifying agents.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC (GSK) today announced that BENLYSTA™ (belimumab) met the primary endpoint in BLISS-76, the second of two pivotal Phase 3 trials in seropositive patients with systemic lupus erythematosus (SLE). BLISS-76 study results through 52 weeks showed that belimumab 10 mg/kg plus standard of care achieved a statistically significant improvement in patient response rate as measured by the SLE Responder Index at Week 52, compared with placebo plus standard of care.
BerGenBio AS today announced the start of a Phase 1 Clinical Trial for BGB324, a first-in-class small molecule inhibitor of AXL tyrosine kinase. BGB324 is a highly selective, oral AXL inhibitor that blocks the epithelial-mesenchymal transition (EMT), which is a key driver of metastasis (cancer spread) and drug-resistance. The Phase 1 clinical trial of BGB324 is a single ascending dose study designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of BGB324.
› Verified 1 days ago
Mrs. Eugenia Leontina Mckelvin, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5529 N Military Trl Apt 1508, Boca Raton, FL 33496 Phone: 240-419-8750 | |
Carissa M Raver, APRN, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 100 Nw 28th St Ste B1, Boca Raton, FL 33431 Phone: 860-713-8875 | |
Ms. Maria Nichole Thomas, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6651 N Military Trl, Boca Raton, FL 33496 Phone: 561-998-3747 Fax: 561-998-3797 | |
Willine Louis, APRN, FNP, PMHNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 980 N Federal Hwy Ste 110, Boca Raton, FL 33432 Phone: 954-604-2227 Fax: 866-544-1159 | |
Crystal Lynn Hummel, MSN, ARNP, AGACNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 670 Glades Rd Ste 310, Boca Raton, FL 33431 Phone: 561-955-6631 | |
Claudine Colin, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9937 Floral Park Ln, Boca Raton, FL 33428 Phone: 561-293-9820 | |
Mrs. Johanna Preisler, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 875 Meadows Rd, Boca Raton, FL 33486 Phone: 561-788-7545 |